ARCELLX
Live / Registered — Registered (as of 06 Feb 2024)
What this means for you
Registered since 06 Feb 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97208593
- Registration number
- 7300306
- Mark type
- Design + words
- Filed
- 07 Jan 2022
- Published for opposition
- 07 Mar 2023
- Registered
- 06 Feb 2024
- Attorney of record
- Aaron D. Hendelman
Goods and services
- Class 005 — Pharmaceuticals: Biological preparations for the treatment of cancer using genetically engineered cells; pharmaceutical preparations for targeting tissues based on select tissue markers and ligands for treating cancer; pharmaceutical preparations for the purpose of binding ligands using receptors for treating cancer; pharmaceutical preparations for immunotherapy using genetically engineered cells for treating cancer
Owner
- Arcellx, Inc., Redwood City, CA, US
- Arcellx, Inc., Gaithersburg, MD, US
- Arcellx, Inc., Gaithersburg, MD, US
Prosecution history
- 13 Feb 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 13 Feb 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 13 Feb 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 13 Feb 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 13 Feb 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 06 Feb 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 06 Feb 2024 — REGISTERED-PRINCIPAL REGISTER
- 04 Jan 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 03 Jan 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 07 Dec 2023 — ASSIGNED TO EXAMINER
- 07 Nov 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 25 Oct 2023 — USE AMENDMENT FILED
- 07 Nov 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 27 Oct 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Oct 2023 — TEAS STATEMENT OF USE RECEIVED